Junevity
Latest round
- Seed
Last raised
- Dec 2025
Total raised
- $20M
Investors
- 2
About Junevity
Junevity Inc. was founded in 2023 in San Francisco, US, specializing in therapies targeting aging-related conditions.Junevity specializes in the development of cell reset therapeutics aimed at combating longevity-related diseases through innovative use of small interfering RNA (siRNA) technology. Their core product offerings leverage the RESET Platform, which utilizes advanced machine learning and high-throughput screening to identify and restore the expression of transcription factors that regulate cellular health. The primary end use cases targeted by Junevity include Obesity, Type 2 Diabetes, and Frailty, addressing conditions that significantly impact global public health. By focusing on cellular damage at the transcriptional level, Junevity aims to reverse the effects of aging and improve quality of life for affected populations.Junevity operates on a model that incorporates both B2B and direct-to-consumer transactions, aiming to establish partnerships with healthcare providers and research institutions. The revenue structure is primarily based on the sale of their novel siRNA therapeutics, which are expected to be priced competitively within the biotechnology market. These therapeutics are positioned as flagship products within their therapeutic pipeline, addressing critical health challenges associated with aging. The transaction process typically involves direct sales to healthcare institutions and potential subscription models for ongoing therapeutic supplies. By focusing on long-term partnerships with stakeholders in the healthcare sector, Junevity is well-positioned to generate sustainable revenue through its innovative approach to disease reversal and longevity enhancement. In November 2025, Junevity Inc.
Who invested in Junevity
2 investors across 2 rounds
See all investors in Junevity
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Junevity
Who invested in Junevity?
Junevity has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Junevity raised?
Junevity has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Junevity last raise money?
Junevity's most recent round on record is a Seed, in Dec 2025.
What does Junevity do?
Junevity is a biotechnology company.
Where is Junevity headquartered?
Junevity is headquartered in San Francisco, US.
Which VCs invest in companies like Junevity?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Junevity's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Junevity? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.